These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1346346)

  • 1. The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
    Sablinski T; Sayegh MH; Kut JP; Tilney NL; Milford EL; Kupiec-Weglinski JW
    Transplantation; 1992 Jan; 53(1):219-21. PubMed ID: 1346346
    [No Abstract]   [Full Text] [Related]  

  • 2. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
    Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
    Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H
    Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
    [No Abstract]   [Full Text] [Related]  

  • 4. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H; Hara MH; Miyahara T; Tanigawa M; Matsuzaki Y; Onitsuka T; Shibata K; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Iwaya M; Miyasaka M; Kimura H
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness.
    Saitovitch D; Bushell AR; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):117-8. PubMed ID: 7878834
    [No Abstract]   [Full Text] [Related]  

  • 6. A short course of cyclosporin A combined with anti-CD4 and/or anti-TCR MAb treatment induces long-term acceptance of kidney allografts in the rat.
    Lácha J; Chadimová M; Havlícková J; Brock J; Matl I; Volk HD; Lehmann M
    Transplant Proc; 1995 Feb; 27(1):125-6. PubMed ID: 7878869
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo immunosuppressive effects of monoclonal antibodies specific for CD3+, CD4+, CD8+, and MHC class II positive cells.
    Stevens HP; Roche N; Hovius SE; Jonker M
    Transplant Proc; 1990 Aug; 22(4):1783-4. PubMed ID: 2143861
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of anti-CD4 monoclonal antibody therapy on rat small bowel allograft survival.
    Bowles MJ; Webster GA; Wood RF; Pockley AG
    Transplant Proc; 1994 Jun; 26(3):1605. PubMed ID: 7913268
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-CD4 therapy induces a donor-specific, organ-nonspecific tolerance in allogeneic kidney graft recipients.
    Kuttler B; Lehmann M; Lacha J; Brock J; Hahn HJ
    Transplant Proc; 1994 Apr; 26(2):728-9. PubMed ID: 8171628
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolongation of kidney and skin allograft survival in the rat by monoclonal antibody therapy directed to the RT6.1 T-cell alloantigen.
    Fangmann J; Schwinzer R; Vogt P; Wonigeit K
    Transplant Proc; 1991 Feb; 23(1 Pt 1):504-6. PubMed ID: 1990601
    [No Abstract]   [Full Text] [Related]  

  • 12. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice.
    Hirsch R; Bluestone JA; Bare CV; Gress RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):270-1. PubMed ID: 1824981
    [No Abstract]   [Full Text] [Related]  

  • 14. CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
    Sablinski T; Hancock WW; Schmidbauer G; Milford EL; Kupiec-Weglinski JW
    Transplant Proc; 1992 Apr; 24(2):528-30. PubMed ID: 1566417
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
    Sablinski T; Sayegh MH; Kut JP; Hancock WW; Milford EL; Tilney NL; Kupiec-Weglinski JW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):268-9. PubMed ID: 1990530
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of anti-CD4-induced T helper cell depletion and inhibition of function. Activation of T cells by the CD3 pathway inhibits anti-CD4-mediated T cell elimination and down-regulation of cell surface CD4.
    Jamali I; Field EH; Fleming A; Cowdery JS
    J Immunol; 1992 Mar; 148(6):1613-9. PubMed ID: 1347302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the immunoregulatory capacity of anti-alpha/beta-TCR and anti-CD3 monoclonal antibodies.
    Kurrle R; Schorlemmer HU; Shearman C; Lauffer L; Frank K; Kanzy EJ; Seiler FR
    Transplant Proc; 1991 Feb; 23(1 Pt 1):272-6. PubMed ID: 1824982
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective T-cell depletion of recipients in allogeneic small bowel transplantation (SBT) in the rat.
    Deaton DH; Posselt AM; Naji A; Barker CF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):283-4. PubMed ID: 1899305
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
    Ellenhorn JD; Schreiber H; Bluestone JA
    J Immunol; 1990 Apr; 144(7):2840-6. PubMed ID: 1969454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.